SCHEMBL13409381

SCHEMBL13409381

CC(C)Oc1ccnc2c(F)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
AR P10275 6/20 0.39
KDM4E B2RXH2 1/20 0.38
PARP1 P09874 1/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
HCRTR2 O43614 4/20 0.37
PSMD14 O00487 1/20 0.37
COPS5 Q92905 1/20 0.37
HCRTR1 O43613 3/20 0.36
MCHR1 Q99705 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CDC7 O00311 1/20 0.36
AURKA O14965 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
CDK1 P06493 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30614513 1.00 MEN1 (0.40) MEN1POLBKMT2AARKDM4E
SCHEMBL7505820 0.82 PPARG (0.38) ARKDM4EADORA2AADORA1HCRTR2
SCHEMBL13409380 0.81 NCF1 (0.46) MEN1POLBKMT2APARP1PSMD14
SCHEMBL4590870 0.81 CCR1 (0.45) MEN1POLBKMT2AMCHR1CYP2C9
SCHEMBL13757501 0.81 NR4A2 (0.51) MEN1POLBKMT2AKDM4EPARP1
SCHEMBL13443834 0.79 ADORA2A (0.53) POLBARKDM4EPARP1ADORA2A
SCHEMBL7507127 0.76 ADORA2A (0.40) ARKDM4EADORA2AADORA1HCRTR2
SCHEMBL7513030 0.76 SLC40A1 (0.38) ARKDM4EADORA2AADORA1HCRTR2
SCHEMBL7067847 0.75 ADORA2A (0.36) KDM4EPARP1ADORA2ACYP2C9
SCHEMBL21173367 0.75 PARP1 (0.41) KDM4EPARP1ADORA2AADORA1PSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705146-B2 Hepatitis C inhibitor peptide analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-27 US disclosed